<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03942991</url>
  </required_header>
  <id_info>
    <org_study_id>14422017496941</org_study_id>
    <nct_id>NCT03942991</nct_id>
  </id_info>
  <brief_title>Anesthetic Efficacy Of 4% ArtpharmaDent Versus 2% Mepecaine-L in Extraction of Lower First Primary Molars</brief_title>
  <official_title>Anesthetic Efficacy Of 4% ArtpharmaDent Versus 2% Mepecaine-L for Infilteration Anesthesia in Extraction of Badly Decayed Lower First Primary Molars: Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      parallel technique will be done where the investigator (will be blinded) will give one type
      on anesthesia then performing the extraction and evaluating the intraoperative pain ,the same
      procedure will be done for the other type of anesthesia.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2019</start_date>
  <completion_date type="Anticipated">December 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intra-Operative Pain during Extraction</measure>
    <time_frame>Immediatly after etxraction</time_frame>
    <description>intraoperative pain will be measured using wong baker pain scale,The scale shows a series of faces ranging from a happy face at 0, or &quot;no hurt&quot;, to a crying face at 10, which represents &quot;hurts like the worst pain imaginable&quot;. Based on the faces and written descriptions, the patient chooses the face that best describes their level of pain Face</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Badly Decayed Lower First Primary Molars in Children</condition>
  <arm_group>
    <arm_group_label>2% Mepecaine-L</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>infiltration injection of 2% Mepivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4% Artpharmadent</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>infiltration injection of 4% Articaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>articaine</intervention_name>
    <description>infiltration injection of 4%artpharmadent</description>
    <arm_group_label>4% Artpharmadent</arm_group_label>
    <other_name>Artpharmadent</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mepivacaine 2% Injection</intervention_name>
    <description>infiltration injection of 2% Mepecaine-L</description>
    <arm_group_label>2% Mepecaine-L</arm_group_label>
    <other_name>2% Mepecaine-L</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children aged 6-8 years.

          -  Medically fit (ASA I, II).

          -  Mentally capable of communication.

          -  Having a mandibular first primary molar tooth that require Extraction.

          -  Child must give assent prior to participation, as well as parental informed written
             consent.

          -  Body weight &gt;20 kg.

          -  it should be the first dental treatment to the child

        Exclusion Criteria:

          -  Medically and mentally compromised children.

          -  Children without a history of prolonged bleeding, platelet disorders,
             hypersensitivity,

          -  History of significant behavior management problems.

          -  Patients having active sites of pathosis in the area of injection.

          -  Patients who had taken analgesics or antibiotics in the 12-hrs preceding the
             injection.

          -  Patients allergic to Articaine and/or Mepivacaine and/or sulfur
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>8 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>May 2, 2019</study_first_submitted>
  <study_first_submitted_qc>May 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 8, 2019</study_first_posted>
  <last_update_submitted>August 27, 2019</last_update_submitted>
  <last_update_submitted_qc>August 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Nadeen Hossam Eldin Hosny Ahmed</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mepivacaine</mesh_term>
    <mesh_term>Carticaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

